Melatonin Mylan (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the suprachiasmatic nucleus of the hypothalamus. Activation of these receptors reduces nighttime neuronal activity and shifts the internal clock, which together promote the onset of sleep and help synchronize the body’s rhythm with the external light‑dark environment.

The appropriate dose of melatonin is determined by the prescribing healthcare professional based on the individual’s age, condition, and response. Dosage may vary widely, and patients should follow the specific instructions provided by their prescriber or pharmacist.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting melatonin therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from traditional sedative hypnotics because it mimics a natural hormone rather than directly depressing the central nervous system. It is generally considered less likely to cause dependence or next‑day impairment, but its efficacy may be modest compared with prescription hypnotics for severe insomnia.

Store Melatonin Mylan at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct light, and ensure the lid is tightly closed to maintain stability.

Melatonin Mylan is taken orally, typically with a glass of water. It is usually taken shortly before the intended bedtime, but the exact timing and any specific administration instructions should follow the prescriber’s guidance.

Serious risks, although rare, include allergic reactions such as rash, itching, or angioedema, severe dizziness or fainting, and mood alterations like depression or agitation. Any of these symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin, those taking interacting medications such as strong CYP1A2 inhibitors or sedative CNS depressants without medical supervision, and patients with uncontrolled epilepsy, severe depression, or autoimmune disorders should avoid using melatonin unless advised otherwise by a healthcare professional.